CJC-1295 is a synthetic peptide believed to function as a growth hormone-releasing hormone (GHRH) analog. It is structurally designed to increase the half-life of endogenous growth hormone-releasing ...
HOUSTON, October 06, 2025--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback